Ken Berlin is the founder of Advaxis. Kenneth Berlin was appointed President and CEO of Advaxis, a Princeton, New Jersey-based oncology biotech, in April 2018.
Kenneth Berlin was appointed President and CEO of Advaxis, a Princeton, New Jersey-based oncology biotech, in April 2018. Prior to Advaxis, he was the CEO of Rosetta Genomics and also held positions at Veridex and Johnson & Johnson. Advaxis focuses on cancer vaccine development, including a neoantigen vaccine in partnership with Amgen.
Full founder directory · Investor directory · Company funding database · Fundraising library